Middle East & Africa Aortic Valve Replacement Devices Market Forecast to 2030 - Regional Analysis - by Product, Surgery, and End User

The Middle East & Africa aortic valve replacement devices market is expected to grow from US$ 279.19 million in 2022 to US$ 625.23 million by 2030. It is estimated to grow at a CAGR of 10.6% from 2022 to 2030.

Increasing Number of Clinical Studies Fuels Middle East & Africa Aortic Valve Replacement Devices Market

A surge in research activity is driven by several factors, including growing prevalence of aortic valve diseases, advancements in medical technology, and need for more evidence-based approaches to treatment. Clinical studies are crucial in assessing the safety and efficacy of new surgical techniques, prosthetic valves, and transcatheter interventions. These studies also help identify risk factors, optimize patient selection criteria, and evaluate long-term outcomes to improve patient care and quality of life. As the demand for aortic valve replacement continues to rise, so does the importance of conducting robust clinical trials to provide healthcare professionals and patients with the best available evidence for making informed treatment options. With ongoing research and collaboration between medical institutions, the future of aortic valve replacement looks promising, with the potential for even more innovative and effective approaches on the horizon.

A few technological advancements by the players in the aortic valve replacement devices are mentioned below:

• Trial started in January 2019, innovative device for pain management by millimeter band radiation: electronic-pain killer (EPIKARD).

Trial started in January 2017, vascular closure device in transcatheter aortic valve replacement. Evaluation of the safety and efficacy of a percutaneous plug-based large-bore vascular closure device for femoral artery closure in an unselected consecutive patient cohort undergoing transcatheter aortic valve implantation in a single-center prospective study.

Middle East & Africa Aortic Valve Replacement Devices Market Overview

The Middle East & Africa aortic valve replacement devices market is categorized into Saudi Arabia, the UAE, South Africa, and the Rest of Middle East & Africa. Saudi Arabia is expected to register the largest share of the market in this region during the forecast period. The flourishing medical tourism sector and growing government initiatives to create awareness about modern healthcare products are the factors contributing to the aortic valve replacement devices market growth in Middle East & Africa.

Middl

e East & Africa Aortic Valve Replacement Devices Market Revenue and Forecast to 2030 (US$ Million)

Middle East & Africa Aortic Valve Replacement Devices Market Segmentation

The Middle East & Africa aortic valve replacement devices market is segmented into product, surgery, end user, and country.

Based on product, the Middle East & Africa aortic valve replacement devices market is segmented into sutureless valve and mechanical valve. The sutureless valve held a larger Middle East & Africa aortic valve replacement devices market share in 2022.

Based on surgery, the Middle East & Africa aortic valve replacement devices market is segmented into minimally invasive surgery and open surgery. The minimally invasive surgery segment held a larger Middle East & Africa aortic valve replacement devices market share in 2022.

Based on end user, the Middle East & Africa aortic valve replacement devices market is segmented into hospitals & clinics, ambulatory surgical centers, and others. The hospitals & clinics segment held the largest Middle East & Africa aortic valve replacement devices market share in 2022.

Based on country, the Middle East & Africa aortic valve replacement devices market has been categorized into Saudi Arabia, the UAE, South Africa, and the Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa aortic valve replacement devices market share in 2022.

Abbott Laboratories, Medtronic Plc, Boston Scientific Corp, LivaNova Plc, Edwards Lifesciences Corp, and Artivion Inc, are some of the leading companies operating in the aortic valve replacement devices market.

Reasons to Buy

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa aortic valve replacement devices market.
• Highlights key business priorities in order to assist companies to realign their business strategies
• The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa aortic valve replacement devices market, thereby allowing players across the value chain to develop effective long-term strategies
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
• Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the aortic valve replacement devices market, as well as those hindering it
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution